Share

Evaluation of the efficacy of pulsed electromagnetic field in the management of patients with diabetic polyneuropathy.

Vinay Graak, Sarika Chaudhary, B S Bal, J S Sandhu

PAPERpubmedInternational journal of diabetes in developing countries2009randomized trialEffect: benefitEvidence: Low

Abstract

AIM: The study was carried out to evaluate and compare the effect of low power, low frequency pulsed electromagnetic field (PEMF) of 600 and 800 Hz, respectively, in management of patients with diabetic polyneuropathy. SETTINGS AND DESIGNS: The study was a randomized controlled trial performed in Guru Nanak Dev University and Medical College, Amritsar, India with different subject experimental design. MATERIALS AND METHODS: Thirty subjects within an age group of 40-68 years with diabetic polyneuropathy stages N1a, N1b, N2a were randomly allocated to groups 1, 2, 3 with 10 subjects in each. Group 1 and 2 were treated with low power 600 and 800-Hz PEMF for 30 min for 12 consecutive days. Group 3 served as control on usual medical treatment of diabetic polyneuropathy (DPN). The subjects with neuropathy due to any cause other than diabetes were excluded. The pain and motor nerve conduction parameters (distal latency, amplitude, nerve conduction velocity) were assessed before and after treatment. STATISTICAL ANALYSIS: Related t-test and unrelated t-test were used for data analysis. RESULTS: Significant reduction in pain and statistically significant (P<0.05) improvement in distal latency and nerve conduction velocity were seen in experimental group 1 and 2. CONCLUSIONS: Low-frequency PEMF can be used as an adjunct in reducing neuropathic pain as well as for retarding the progression of neuropathy in a short span of time.

AI evidence extraction

At a glance
Study type
randomized trial
Effect direction
benefit
Population
Adults aged 40–68 years with diabetic polyneuropathy (stages N1a, N1b, N2a)
Sample size
30
Exposure
ELF therapeutic PEMF device · 30 min for 12 consecutive days
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

In both PEMF groups (600 Hz and 800 Hz), the study reports significant reduction in pain and statistically significant (P<0.05) improvement in distal latency and nerve conduction velocity compared with baseline (and relative to the control group as described).

Outcomes measured

  • Pain
  • Motor nerve conduction parameters: distal latency
  • Motor nerve conduction parameters: amplitude
  • Motor nerve conduction parameters: nerve conduction velocity

Limitations

  • Small sample size (10 per group)
  • Short treatment duration (12 days)
  • Power/intensity of PEMF not quantified beyond 'low power'
  • Blinding/sham control not described in the abstract
  • Amplitude outcome mentioned as assessed but results for amplitude not reported in the abstract
View raw extracted JSON
{
  "study_type": "randomized_trial",
  "exposure": {
    "band": "ELF",
    "source": "therapeutic PEMF device",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": "30 min for 12 consecutive days"
  },
  "population": "Adults aged 40–68 years with diabetic polyneuropathy (stages N1a, N1b, N2a)",
  "sample_size": 30,
  "outcomes": [
    "Pain",
    "Motor nerve conduction parameters: distal latency",
    "Motor nerve conduction parameters: amplitude",
    "Motor nerve conduction parameters: nerve conduction velocity"
  ],
  "main_findings": "In both PEMF groups (600 Hz and 800 Hz), the study reports significant reduction in pain and statistically significant (P<0.05) improvement in distal latency and nerve conduction velocity compared with baseline (and relative to the control group as described).",
  "effect_direction": "benefit",
  "limitations": [
    "Small sample size (10 per group)",
    "Short treatment duration (12 days)",
    "Power/intensity of PEMF not quantified beyond 'low power'",
    "Blinding/sham control not described in the abstract",
    "Amplitude outcome mentioned as assessed but results for amplitude not reported in the abstract"
  ],
  "evidence_strength": "low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "pulsed electromagnetic field",
    "PEMF",
    "low frequency",
    "600 Hz",
    "800 Hz",
    "diabetic polyneuropathy",
    "neuropathic pain",
    "nerve conduction velocity",
    "randomized controlled trial"
  ],
  "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 3358

Evaluation of the efficacy of pulsed electromagnetic field in the management of patients with diabetic polyneuropathy. · Non-native EMF